These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 30453889

  • 1. Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).
    Schimpf JI, Klein T, Fitzner C, Eitner F, Porubsky S, Hilgers RD, Floege J, Groene HJ, Rauen T.
    BMC Nephrol; 2018 Nov 19; 19(1):328. PubMed ID: 30453889
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.
    Pediatr Nephrol; 2017 Jan 19; 32(1):139-150. PubMed ID: 27557557
    [Abstract] [Full Text] [Related]

  • 3. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N.
    J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226
    [Abstract] [Full Text] [Related]

  • 4. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L, Benito A, Oviedo MV, López Del Moral Cuesta C, Martín López J, Gómez Román J, López-Mejías R, Fernandez-Fresnedo G, Ruíz San Millán JC, Rodrigo Calabia E.
    Nefrologia (Engl Ed); 2019 May 03; 39(5):523-530. PubMed ID: 30902505
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A, MacEwen C, Bellur SS, Chompuk LO, Lunn D, Roberts ISD.
    J Nephrol; 2016 Jun 03; 29(3):367-375. PubMed ID: 26318019
    [Abstract] [Full Text] [Related]

  • 6. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC, Oxford Derivation, North American Validation and VALIGA Consortia, Oxford Derivation North American Validation and VALIGA Consortia.
    Kidney Int; 2016 Jan 03; 89(1):167-75. PubMed ID: 26759049
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of Oxford classification in assessing immunoglobulin A nephropathy after transplantation.
    Lim BJ, Joo DJ, Kim MS, Kim YS, Kim SI, Kim Y, Huh KH, Koh MJ, Jeong HJ.
    Transplantation; 2013 Jun 27; 95(12):1491-7. PubMed ID: 23677050
    [Abstract] [Full Text] [Related]

  • 8. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, Wang M, Peng Y.
    BMC Nephrol; 2020 Jul 01; 21(1):247. PubMed ID: 32611399
    [Abstract] [Full Text] [Related]

  • 9. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J, IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology SocietyHospital Británico de Buenos Aires, Argentina., Conference Participants.
    Kidney Int; 2017 May 01; 91(5):1014-1021. PubMed ID: 28341274
    [Abstract] [Full Text] [Related]

  • 10. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Asunis AM, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez E, Asma Haider S, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, Tardanico R.
    Nephrol Dial Transplant; 2019 Oct 01; 34(10):1681-1690. PubMed ID: 30561721
    [Abstract] [Full Text] [Related]

  • 11. Clinical and histological differences between adults and children in new onset IgA nephropathy.
    Cambier A, Rabant M, El Karoui K, Peuchmaur M, Servais A, Hertig A, Deschenes G, Salomon R, Hogan J, Robert T.
    Pediatr Nephrol; 2020 Oct 01; 35(10):1897-1905. PubMed ID: 32444925
    [Abstract] [Full Text] [Related]

  • 12. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.
    Bobart SA, Alexander MP, Shawwa K, Vaughan LE, Ghamrawi R, Sethi S, Cornell L, Glassock RJ, Fervenza FC, Zand L.
    Nephrol Dial Transplant; 2021 Apr 26; 36(5):840-847. PubMed ID: 31859353
    [Abstract] [Full Text] [Related]

  • 13. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C, ERA-EDTA Immunonephrology Working Group.
    Nephrol Dial Transplant; 2020 Jun 01; 35(6):1002-1009. PubMed ID: 30418652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pediatric IgA Nephropathy in Europe.
    Coppo R.
    Kidney Dis (Basel); 2019 Jun 01; 5(3):182-188. PubMed ID: 31259180
    [Abstract] [Full Text] [Related]

  • 16. The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in Patients with IgA Nephropathy.
    Ossareh S, Nazemzadeh N, Asgari M, Bagherzadegan H, Afghahi H.
    Iran J Kidney Dis; 2022 Mar 01; 16(2):115-124. PubMed ID: 35489080
    [Abstract] [Full Text] [Related]

  • 17. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J, Lv J, Wang W, Li G, Liu Z, Chen H, Xu F, Sun J, Ouyang Y, Zhang X, Yang M, Shi M, Zhang W, Ren H, Kiryluk K, Zhang H, Chen N.
    Am J Kidney Dis; 2018 Sep 01; 72(3):371-380. PubMed ID: 29555434
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classification
.
    Woo KT, Lim CC, Foo MW, Loh HL, Jin AZ, Chin YM, Choo JC, Tan PH, Chow KY, Choong LH, Tan HK, Wong KS, Chan CM.
    Clin Nephrol; 2016 Nov 01; 86 (2016)(11):270-278. PubMed ID: 27641054
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.